TLR7 and systemic lupus erythematosus: These data support the concept that endogenous ligands of TLR7 and TLR9 contribute to the pathogenesis of autoantibody production and autoimmune tissue injury in SLE and provide a new strategy for exploring lupus therapeutic agents.